{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:41:03Z","timestamp":1793911263724,"version":"4.8.0"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100015382","name":"Universiti Sultan Zainal Abidin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015382","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05602-0","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T06:04:37Z","timestamp":1765433077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Toward a Unified Framework in Molecular Neurobiology of Alzheimer\u2019s Disease: Revisiting the Pathophysiological Hypotheses"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7621-7132","authenticated-orcid":false,"given":"Zaw Myo","family":"Hein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5751-346X","authenticated-orcid":false,"given":"Barani","family":"Karikalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1428-5305","authenticated-orcid":false,"given":"Prarthana Kalerammana","family":"Gopalakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7349-884X","authenticated-orcid":false,"given":"Krina","family":"Dhevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1522-4085","authenticated-orcid":false,"given":"Aisyah","family":"Alkatiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0197-4646","authenticated-orcid":false,"given":"Farida","family":"Hussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9282-129X","authenticated-orcid":false,"given":"Mohamad Aris","family":"Mohd Moklas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7389-7363","authenticated-orcid":false,"given":"Saravanan","family":"Jagadeesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Danial","family":"Che Ramli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2019-4565","authenticated-orcid":false,"given":"Che Mohd Nasril","family":"Che Mohd Nassir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9517-3726","authenticated-orcid":false,"given":"Thirupathirao","family":"Vishnumukkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"3","key":"5602_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.14283\/jpad.2021.15","volume":"8","author":"XX Zhang","year":"2021","unstructured":"Zhang XX, Tian Y, Wang ZT, Ma YH, Tan L, Yu JT (2021) The epidemiology of Alzheimer\u2019s disease modifiable risk factors and prevention. J Prev Alzheimers Dis 8(3):313\u2013321. https:\/\/doi.org\/10.14283\/jpad.2021.15","journal-title":"J Prev Alzheimers Dis"},{"key":"5602_CR2","doi-asserted-by":"publisher","first-page":"1585711","DOI":"10.3389\/fpubh.2025.1585711","volume":"13","author":"Z Xiaopeng","year":"2025","unstructured":"Xiaopeng Z, Jing Y, Xia L, Xingsheng W, Juan D, Yan L, Baoshan L (2025) Global burden of Alzheimer\u2019s disease and other dementias in adults aged 65 years and older, 1991\u20132021: population-based study. Front Public Health 13:1585711. https:\/\/doi.org\/10.3389\/fpubh.2025.1585711","journal-title":"Front Public Health"},{"issue":"8","key":"5602_CR3","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1093\/aje\/kwac063","volume":"191","author":"MM Glymour","year":"2022","unstructured":"Glymour MM, Weuve J, Dufouil C, Mayeda ER (2022) Aduhelm, the newly approved medication for Alzheimer disease: what epidemiologists can learn and what epidemiology can offer. Am J Epidemiol 191(8):1347\u20131351. https:\/\/doi.org\/10.1093\/aje\/kwac063","journal-title":"Am J Epidemiol"},{"issue":"6","key":"5602_CR4","doi-asserted-by":"publisher","first-page":"e85377","DOI":"10.7759\/cureus.85377","volume":"17","author":"UC Chundu","year":"2025","unstructured":"Chundu UC, Thiriveedhi SR, Bhatti C, Mupparaju JS, Otinashvili N, Gelishvili E (2025) A systematic review of the efficacy and safety of anti-amyloid monoclonal antibodies in Alzheimer\u2019s disease. Cureus 17(6):e85377. https:\/\/doi.org\/10.7759\/cureus.85377","journal-title":"Cureus"},{"issue":"5","key":"5602_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0045-1808082","volume":"83","author":"R Nitrini","year":"2025","unstructured":"Nitrini R, Studart-Neto A (2025) Monoclonal antibodies against beta-amyloid protein (lecanemab and donanemab) should not be used in the treatment of Alzheimer\u2019s disease. Arq Neuropsiquiatr 83(5):1\u20135. https:\/\/doi.org\/10.1055\/s-0045-1808082","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"5602_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5114\/fn.2014.45562","volume":"52","author":"RA Armstrong","year":"2014","unstructured":"Armstrong RA (2014) A critical analysis of the \u201camyloid cascade hypothesis.\u201d Folia Neuropathol 52(3):211\u2013225","journal-title":"Folia Neuropathol"},{"issue":"9","key":"5602_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discovery 10(9):698\u2013712. https:\/\/doi.org\/10.1038\/nrd3505","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"5602_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40035-022-00292-3","volume":"11","author":"C Song","year":"2022","unstructured":"Song C, Shi J, Zhang P, Zhang Y, Xu J, Zhao L, Zhang R, Wang H et al (2022) Immunotherapy for Alzheimer\u2019s disease: targeting \u03b2-amyloid and beyond. Transl Neurodegener 11(1):18. https:\/\/doi.org\/10.1186\/s40035-022-00292-3","journal-title":"Transl Neurodegener"},{"issue":"1","key":"5602_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/cm.21822","volume":"81","author":"K Iqbal","year":"2024","unstructured":"Iqbal K (2024) Tau and Alzheimer\u2019s disease: past, present and future. Cytoskeleton 81(1):116\u2013121. https:\/\/doi.org\/10.1002\/cm.21822","journal-title":"Cytoskeleton"},{"issue":"4","key":"5602_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3233\/jad-2008-14409","volume":"14","author":"NS Honson","year":"2008","unstructured":"Honson NS, Kuret J (2008) Tau aggregation and toxicity in tauopathic neurodegenerative diseases. J Alzheimer\u2019s Dis: JAD 14(4):417\u2013422. https:\/\/doi.org\/10.3233\/jad-2008-14409","journal-title":"J Alzheimer's Dis: JAD"},{"issue":"7","key":"5602_CR11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.2174\/1570159X18666201111104509","volume":"19","author":"S Hashioka","year":"2021","unstructured":"Hashioka S, Wu Z, Klegeris A (2021) Glia-driven neuroinflammation and systemic inflammation in Alzheimer\u2019s disease. Curr Neuropharmacol 19(7):908\u2013924. https:\/\/doi.org\/10.2174\/1570159X18666201111104509","journal-title":"Curr Neuropharmacol"},{"issue":"19","key":"5602_CR12","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.2174\/0929867321666131227161303","volume":"21","author":"G Aliev","year":"2014","unstructured":"Aliev G, Priyadarshini M, Reddy VP, Grieg NH, Kaminsky Y, Cacabelos R, Ashraf GM, Jabir NR et al (2014) Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease. Curr Med Chem 21(19):2208\u20132217. https:\/\/doi.org\/10.2174\/0929867321666131227161303","journal-title":"Curr Med Chem"},{"issue":"3","key":"5602_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1124\/jpet.102.041616","volume":"306","author":"AV Terry Jr","year":"2003","unstructured":"Terry AV Jr, Buccafusco JJ (2003) The cholinergic hypothesis of age and Alzheimer\u2019s disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306(3):821\u2013827. https:\/\/doi.org\/10.1124\/jpet.102.041616","journal-title":"J Pharmacol Exp Ther"},{"key":"5602_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2024.115212","volume":"476","author":"NA Althobaiti","year":"2025","unstructured":"Althobaiti NA (2025) Heavy metals exposure and Alzheimer\u2019s disease: underlying mechanisms and advancing therapeutic approaches. Behav Brain Res 476:115212. https:\/\/doi.org\/10.1016\/j.bbr.2024.115212","journal-title":"Behav Brain Res"},{"issue":"2\u20133","key":"5602_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/jad-2006-102-303","volume":"10","author":"PA Adlard","year":"2006","unstructured":"Adlard PA, Bush AI (2006) Metals and Alzheimer\u2019s disease. J Alzheimer\u2019s Dis: JAD 10(2\u20133):145\u2013163. https:\/\/doi.org\/10.3233\/jad-2006-102-303","journal-title":"J Alzheimer's Dis: JAD"},{"issue":"5","key":"5602_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/alzrt217","volume":"5","author":"ME Orr","year":"2013","unstructured":"Orr ME, Oddo S (2013) Autophagic\/lysosomal dysfunction in Alzheimer\u2019s disease. Alzheimers Res Ther 5(5):53. https:\/\/doi.org\/10.1186\/alzrt217","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"5602_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-025-00843-y","volume":"20","author":"AA Belaidi","year":"2025","unstructured":"Belaidi AA, Bush AI, Ayton S (2025) Apolipoprotein E in Alzheimer\u2019s disease: molecular insights and therapeutic opportunities. Mol Neurodegener 20(1):47. https:\/\/doi.org\/10.1186\/s13024-025-00843-y","journal-title":"Mol Neurodegener"},{"issue":"1","key":"5602_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13024-022-00559-3","volume":"17","author":"T Ganz","year":"2022","unstructured":"Ganz T, Fainstein N, Ben-Hur T (2022) When the infectious environment meets the AD brain. Mol Neurodegener 17(1):53. https:\/\/doi.org\/10.1186\/s13024-022-00559-3","journal-title":"Mol Neurodegener"},{"issue":"10","key":"5602_CR19","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.1038\/s41380-021-01138-6","volume":"26","author":"M Wainberg","year":"2021","unstructured":"Wainberg M, Luquez T, Koelle DM, Readhead B, Johnston C, Darvas M, Funk CC (2021) The viral hypothesis: how herpesviruses may contribute to Alzheimer\u2019s disease. Mol Psychiatry 26(10):5476\u20135480. https:\/\/doi.org\/10.1038\/s41380-021-01138-6","journal-title":"Mol Psychiatry"},{"issue":"3\u20134","key":"5602_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000505625","volume":"19","author":"J Klohs","year":"2019","unstructured":"Klohs J (2019) An integrated view on vascular dysfunction in Alzheimer\u2019s disease. Neurodegener Dis 19(3\u20134):109\u2013127. https:\/\/doi.org\/10.1159\/000505625","journal-title":"Neurodegener Dis"},{"issue":"6","key":"5602_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P (2016) Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheimers Dement 12(6):719\u2013732. https:\/\/doi.org\/10.1016\/j.jalz.2016.02.010","journal-title":"Alzheimers Dement"},{"issue":"9","key":"5602_CR22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2174\/1871527317666180816100203","volume":"17","author":"A Kumar","year":"2018","unstructured":"Kumar A, Dhawan A, Kadam A, Shinde A (2018) Autophagy and mitochondria: targets in neurodegenerative disorders. CNS Neurol Disord Drug Targets 17(9):696\u2013705. https:\/\/doi.org\/10.2174\/1871527317666180816100203","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"4","key":"5602_CR23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE et al (2022) New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet 54(4):412\u2013436. https:\/\/doi.org\/10.1038\/s41588-022-01024-z","journal-title":"Nat Genet"},{"issue":"5054","key":"5602_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256(5054):184\u2013185","journal-title":"Science"},{"issue":"6","key":"5602_CR25","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.14336\/AD.2022.0412","volume":"13","author":"T Wu","year":"2022","unstructured":"Wu T, Lin D, Cheng Y, Jiang S, Riaz MW, Fu N, Mou C, Ye M et al (2022) Amyloid cascade hypothesis for the treatment of Alzheimer\u2019s disease: progress and challenges. Aging Dis 13(6):1745\u20131758. https:\/\/doi.org\/10.14336\/AD.2022.0412","journal-title":"Aging Dis"},{"issue":"12","key":"5602_CR26","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/membranes11120983","volume":"11","author":"X Liu","year":"2021","unstructured":"Liu X, Liu Y, Ji S (2021) Secretases related to amyloid precursor protein processing. Membranes 11(12):983. https:\/\/doi.org\/10.3390\/membranes11120983","journal-title":"Membranes"},{"key":"5602_CR27","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1007\/s11357-024-01118-y","volume":"46","author":"M Pszczo\u0142owska","year":"2024","unstructured":"Pszczo\u0142owska M, Walczak K, Mi\u015bk\u00f3w W et al (2024) Mitochondrial disorders leading to Alzheimer\u2019s disease\u2014perspectives of diagnosis and treatment. Geroscience 46:2977\u20132988. https:\/\/doi.org\/10.1007\/s11357-024-01118-y","journal-title":"Geroscience"},{"issue":"1","key":"5602_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-021-00465-0","volume":"16","author":"MM Rahman","year":"2021","unstructured":"Rahman MM, Lendel C (2021) Extracellular protein components of amyloid plaques and their roles in Alzheimer\u2019s disease pathology. Mol Neurodegener 16(1):59. https:\/\/doi.org\/10.1186\/s13024-021-00465-0","journal-title":"Mol Neurodegener"},{"key":"5602_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R et al (2023) Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Sig Transduct Target Ther 8:248. https:\/\/doi.org\/10.1038\/s41392-023-01484-7","journal-title":"Sig Transduct Target Ther"},{"issue":"19","key":"5602_CR30","doi-asserted-by":"publisher","first-page":"14794","DOI":"10.3390\/ijms241914794","volume":"24","author":"S Mohammadi","year":"2023","unstructured":"Mohammadi S, Naghavi FS, Mahi-Birjand M, Yousefi K, Babajani A, Khorasani MS, Niknejad H (2023) Amyloid precursor protein and Alzheimer\u2019s disease. Int J Mol Sci 24(19):14794. https:\/\/doi.org\/10.3390\/ijms241914794","journal-title":"Int J Mol Sci"},{"key":"5602_CR31","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K et al (2021) The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry 26:5481\u20135503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0","journal-title":"Mol Psychiatry"},{"issue":"16","key":"5602_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe4499","volume":"7","author":"G Chen","year":"2021","unstructured":"Chen G, Kang SS, Wang Z, Ahn EH, Xia Y, Liu X, Sandoval IM, Manfredsson FP, et al. (2021) Netrin-1 receptor UNC5C cleavage by active \u03b4-secretase enhances neurodegeneration, promoting Alzheimer\u2019s disease pathologies. Sci Adv 7(16):eabe4499. https:\/\/doi.org\/10.1126\/sciadv.abe4499","journal-title":"Sci Adv"},{"issue":"18","key":"5602_CR33","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1111\/bph.14554","volume":"176","author":"MIG Lopez Sanchez","year":"2019","unstructured":"Lopez Sanchez MIG, van Wijngaarden P, Trounce IA (2019) Amyloid precursor protein-mediated mitochondrial regulation and Alzheimer\u2019s disease. Br J Pharmacol 176(18):3464\u20133474. https:\/\/doi.org\/10.1111\/bph.14554","journal-title":"Br J Pharmacol"},{"issue":"6","key":"5602_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101911","volume":"298","author":"L Hitschler","year":"2022","unstructured":"Hitschler L, Lang T (2022) The transmembrane domain of the amyloid precursor protein is required for antiamyloidogenic processing by \u03b1-secretase ADAM10. J Biol Chem 298(6):101911. https:\/\/doi.org\/10.1016\/j.jbc.2022.101911","journal-title":"J Biol Chem"},{"key":"5602_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101451","volume":"71","author":"R Ullah","year":"2021","unstructured":"Ullah R, Park TJ, Huang X, Kim MO (2021) Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer\u2019s pathology: insights and therapeutic approaches from periphery. Ageing Res Rev 71:101451. https:\/\/doi.org\/10.1016\/j.arr.2021.101451","journal-title":"Ageing Res Rev"},{"key":"5602_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.634948","volume":"13","author":"D Wu","year":"2021","unstructured":"Wu D, Hu Y, Song M, Li G (2021) Dichlorodiphenyltrichloroethane impairs amyloid beta clearance by decreasing liver X receptor \u03b1 expression. Front Aging Neurosci 13:634948. https:\/\/doi.org\/10.3389\/fnagi.2021.634948","journal-title":"Front Aging Neurosci"},{"key":"5602_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neurobiolaging.2020.02.001","volume":"93","author":"D Krishnan","year":"2020","unstructured":"Krishnan D, Menon RN, Mathuranath PS, Gopala S (2020) A novel role for SHARPIN in amyloid-\u03b2 phagocytosis and inflammation by peripheral blood-derived macrophages in Alzheimer\u2019s disease. Neurobiol Aging 93:131\u2013141. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.02.001","journal-title":"Neurobiol Aging"},{"key":"5602_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","volume":"140","author":"SA Kent","year":"2020","unstructured":"Kent SA, Spires-Jones TL, Durrant CS (2020) The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics. Acta Neuropathol 140:417\u2013447. https:\/\/doi.org\/10.1007\/s00401-020-02196-w","journal-title":"Acta Neuropathol"},{"key":"5602_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","volume":"28","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ye X, Escames G et al (2023) The NLRP3 inflammasome: contributions to inflammation-related diseases. Cell Mol Biol Lett 28:51. https:\/\/doi.org\/10.1186\/s11658-023-00462-9","journal-title":"Cell Mol Biol Lett"},{"issue":"3","key":"5602_CR40","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3233\/JAD-210268","volume":"83","author":"M Van Zeller","year":"2021","unstructured":"Van Zeller M, Dias D, Sebasti\u00e3o AM, Valente CA (2021) NLRP3 inflammasome: a starring role in amyloid-\u03b2- and tau-driven pathological events in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis: JAD 83(3):939\u2013961. https:\/\/doi.org\/10.3233\/JAD-210268","journal-title":"J Alzheimer's Dis: JAD"},{"key":"5602_CR41","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3389\/fnins.2019.01154","volume":"13","author":"H Hillen","year":"2019","unstructured":"Hillen H (2019) The beta amyloid dysfunction (BAD) hypothesis for Alzheimer\u2019s disease. Front Neurosci 13:1154. https:\/\/doi.org\/10.3389\/fnins.2019.01154","journal-title":"Front Neurosci"},{"issue":"6","key":"5602_CR42","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1570159X15666170116143743","volume":"15","author":"R Ricciarelli","year":"2017","unstructured":"Ricciarelli R, Fedele E (2017) The amyloid cascade hypothesis in Alzheimer\u2019s disease: it\u2019s time to change our mind. Curr Neuropharmacol 15(6):926\u2013935. https:\/\/doi.org\/10.2174\/1570159X15666170116143743","journal-title":"Curr Neuropharmacol"},{"key":"5602_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuroscience.2015.08.039","volume":"307","author":"D Puzzo","year":"2015","unstructured":"Puzzo D, Gulisano W, Arancio O, Palmeri A (2015) The keystone of Alzheimer pathogenesis might be sought in A\u03b2 physiology. Neuroscience 307:26\u201336. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.08.039","journal-title":"Neuroscience"},{"issue":"21","key":"5602_CR44","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/ijms232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH (2022) Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 23(21):12841. https:\/\/doi.org\/10.3390\/ijms232112841","journal-title":"Int J Mol Sci"},{"key":"5602_CR45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y (2023) Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflammation 20:165. https:\/\/doi.org\/10.1186\/s12974-023-02853-3","journal-title":"J Neuroinflammation"},{"issue":"2","key":"5602_CR46","doi-asserted-by":"publisher","first-page":"414","DOI":"10.14283\/jpad.2024.15","volume":"11","author":"AC Macedo","year":"2024","unstructured":"Macedo AC, Dur\u00e7o DFPA, Tissot C, Therriault J, de Vilela Faria AO, Aumont \u00c9, Servaes S, Rahmouni N et al (2024) Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer\u2019s Disease. J Prev Alzheimer\u2019s Dis 11(2):414\u2013421. https:\/\/doi.org\/10.14283\/jpad.2024.15","journal-title":"J Prev Alzheimer's Dis"},{"issue":"2","key":"5602_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5414\/npp30056","volume":"30","author":"H Brunnstr\u00f6m","year":"2011","unstructured":"Brunnstr\u00f6m H, Englund E (2011) Comparison of four neuropathological scales for Alzheimer\u2019s disease. Clin Neuropathol 30(2):56\u201369. https:\/\/doi.org\/10.5414\/npp30056","journal-title":"Clin Neuropathol"},{"issue":"1","key":"5602_CR48","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/alz.12370","volume":"18","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Kuca K, Wu W, Wang X, Nepovimova E, Musilek K, Wu Q (2022) Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases. Alzheimers Dement 18(1):152\u2013158. https:\/\/doi.org\/10.1002\/alz.12370","journal-title":"Alzheimers Dement"},{"key":"5602_CR49","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41380-023-02113-z","volume":"28","author":"N Basheer","year":"2023","unstructured":"Basheer N, Smolek T, Hassan I et al (2023) Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer\u2019s disease? From preclinical studies to the clinical trials. Mol Psychiatry 28:2197\u20132214. https:\/\/doi.org\/10.1038\/s41380-023-02113-z","journal-title":"Mol Psychiatry"},{"issue":"9","key":"5602_CR50","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.7150\/ijbs.57078","volume":"17","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wei W, Zhao M, Ma L, Jiang X, Pei H, Cao Y, Li H (2021) Interaction between A\u03b2 and Tau in the pathogenesis of Alzheimer\u2019s disease. Int J Biol Sci 17(9):2181\u20132192. https:\/\/doi.org\/10.7150\/ijbs.57078","journal-title":"Int J Biol Sci"},{"issue":"11","key":"5602_CR51","doi-asserted-by":"publisher","first-page":"8816","DOI":"10.3390\/cimb45110553","volume":"45","author":"R Davidson","year":"2023","unstructured":"Davidson R, Krider RI, Borsellino P, Noorda K, Alhwayek G, Vida TA (2023) Untangling tau: molecular insights into neuroinflammation, pathophysiology, and emerging immunotherapies. Curr Issues Mol Biol 45(11):8816\u20138839. https:\/\/doi.org\/10.3390\/cimb45110553","journal-title":"Curr Issues Mol Biol"},{"key":"5602_CR52","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","volume":"163","author":"S Muralidar","year":"2020","unstructured":"Muralidar S, Ambi SV, Sekaran S, Thirumalai D, Palaniappan B (2020) Role of tau protein in Alzheimer\u2019s disease: the prime pathological player. Int J Biol Macromol 163:1599\u20131617. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.07.327","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"5602_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2023.10.002","volume":"21","author":"MM Klemmensen","year":"2024","unstructured":"Klemmensen MM, Borrowman SH, Pearce C, Pyles B, Chandra B (2024) Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics 21(1):e00292. https:\/\/doi.org\/10.1016\/j.neurot.2023.10.002","journal-title":"Neurotherapeutics"},{"key":"5602_CR54","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","volume":"63","author":"RH Swerdlow","year":"2004","unstructured":"Swerdlow RH, Khan SM (2004) A \u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer\u2019s disease. Med Hypotheses 63:8\u201320. https:\/\/doi.org\/10.1016\/j.mehy.2003.12.045","journal-title":"Med Hypotheses"},{"issue":"23","key":"5602_CR55","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1093\/hmg\/ddr381","volume":"20","author":"MJ Calkins","year":"2011","unstructured":"Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH (2011) Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer\u2019s disease. Hum Mol Genet 20(23):4515\u20134529","journal-title":"Hum Mol Genet"},{"issue":"7","key":"5602_CR56","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/jcmm.17696","volume":"27","author":"X Yang","year":"2023","unstructured":"Yang X, Zhuang J, Song W, Shen W, Wu W, Shen H, Han S (2023) Mitochondria-associated endoplasmic reticulum membrane: overview and inextricable link with cancer. J Cell Mol Med 27(7):906\u2013919. https:\/\/doi.org\/10.1111\/jcmm.17696","journal-title":"J Cell Mol Med"},{"issue":"9","key":"5602_CR57","doi-asserted-by":"publisher","first-page":"8398","DOI":"10.3390\/ijms24098398","volume":"24","author":"M Song","year":"2023","unstructured":"Song M, Fan X (2023) Systemic metabolism and mitochondria in the mechanism of Alzheimer\u2019s disease: finding potential therapeutic targets. Int J Mol Sci 24(9):8398. https:\/\/doi.org\/10.3390\/ijms24098398","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5602_CR58","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/ars.2020.8070","volume":"34","author":"Y Mi","year":"2021","unstructured":"Mi Y, Qi G, Brinton RD, Yin F (2021) Mitochondria-targeted therapeutics for Alzheimer\u2019s disease: the good, the bad, the potential. Antioxid Redox Signal 34(8):611\u2013630. https:\/\/doi.org\/10.1089\/ars.2020.8070","journal-title":"Antioxid Redox Signal"},{"key":"5602_CR59","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/bs.pmbts.2016.12.017","volume":"146","author":"RH Swerdlow","year":"2017","unstructured":"Swerdlow RH, Koppel S, Weidling I, Hayley C, Ji Y, Wilkins HM (2017) Mitochondria, cybrids, aging, and Alzheimer\u2019s disease. Prog Mol Biol Transl Sci 146:259\u2013302. https:\/\/doi.org\/10.1016\/bs.pmbts.2016.12.017","journal-title":"Prog Mol Biol Transl Sci"},{"key":"5602_CR60","doi-asserted-by":"publisher","first-page":"1585508","DOI":"10.3389\/fragi.2025.1585508","volume":"6","author":"DM Miller","year":"2025","unstructured":"Miller DM, Archer SL, Dunham-Snary KJ (2025) Preclinical models of mitochondrial dysfunction: mtDNA and nuclear-encoded regulators in diverse pathologies. Front Aging 6:1585508. https:\/\/doi.org\/10.3389\/fragi.2025.1585508","journal-title":"Front Aging"},{"key":"5602_CR61","doi-asserted-by":"publisher","first-page":"1158204","DOI":"10.3389\/fnins.2023.1158204","volume":"17","author":"Z Li","year":"2023","unstructured":"Li Z, Cao Y, Pei H, Ma L, Yang Y, Li H (2023) The contribution of mitochondria-associated endoplasmic reticulum membranes (MAMs) dysfunction in Alzheimer\u2019s disease and the potential countermeasure. Front Neurosci 17:1158204. https:\/\/doi.org\/10.3389\/fnins.2023.1158204","journal-title":"Front Neurosci"},{"issue":"1","key":"5602_CR62","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-025-02179-x","volume":"10","author":"X Wu","year":"2025","unstructured":"Wu X, Yang Z, Zou J, Gao H, Shao Z, Li C, Lei P (2025) Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery. Signal Transduct Target Ther 10(1):146. https:\/\/doi.org\/10.1038\/s41392-025-02179-x","journal-title":"Signal Transduct Target Ther"},{"key":"5602_CR63","unstructured":"Pirahanchi Y, Jessu R, Aeddula NR. Physiology, Sodium Potassium Pump. [Updated 2023 Mar 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537088\/"},{"issue":"21","key":"5602_CR64","doi-asserted-by":"publisher","first-page":"11720","DOI":"10.3390\/ijms252111720","volume":"25","author":"S Kazemeini","year":"2024","unstructured":"Kazemeini S, Nadeem-Tariq A, Shih R, Rafanan J, Ghani N, Vida TA (2024) From plaques to pathways in Alzheimer\u2019s disease: the mitochondrial-neurovascular-metabolic hypothesis. Int J Mol Sci 25(21):11720. https:\/\/doi.org\/10.3390\/ijms252111720","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5602_CR65","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.2174\/1567205013666160415154550","volume":"13","author":"M Zhou","year":"2016","unstructured":"Zhou M, Huang T, Collins N, Zhang J, Shen H, Dai X, Xiao N, Wu X et al (2016) APOE4 induces site-specific tau phosphorylation through calpain-CDK5 signaling pathway in EFAD-Tg mice. Curr Alzheimer Res 13(9):1048\u20131055. https:\/\/doi.org\/10.2174\/1567205013666160415154550","journal-title":"Curr Alzheimer Res"},{"issue":"16","key":"5602_CR66","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.3390\/cells12162019","volume":"12","author":"S Raut","year":"2023","unstructured":"Raut S, Bhalerao A, Powers M, Gonzalez M, Mancuso S, Cucullo L (2023) Hypometabolism, Alzheimer\u2019s disease, and possible therapeutic targets: an overview. Cells 12(16):2019. https:\/\/doi.org\/10.3390\/cells12162019","journal-title":"Cells"},{"key":"5602_CR67","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13195-022-00996-8","volume":"14","author":"A Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez A, Calf\u00edo C, Churruca M et al (2022) Glucose metabolism and AD: evidence for a potential diabetes type 3. Alz Res Ther 14:56. https:\/\/doi.org\/10.1186\/s13195-022-00996-8","journal-title":"Alz Res Ther"},{"key":"5602_CR68","doi-asserted-by":"publisher","first-page":"101795","DOI":"10.1016\/j.nicl.2019.101795","volume":"22","author":"MD Paranjpe","year":"2019","unstructured":"Paranjpe MD, Chen X, Liu M, Paranjpe I, Leal JP, Wang R, Pomper MG, Wong DF et al (2019) The effect of ApoE \u03b54 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study. NeuroImage Clin 22:101795. https:\/\/doi.org\/10.1016\/j.nicl.2019.101795","journal-title":"NeuroImage Clin"},{"issue":"15","key":"5602_CR69","doi-asserted-by":"publisher","first-page":"e1592","DOI":"10.1212\/WNL.0000000000009249","volume":"94","author":"T Terada","year":"2020","unstructured":"Terada T, Obi T, Bunai T, Matsudaira T, Yoshikawa E, Ando I, Futatsubashi M, Tsukada H et al (2020) In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease. Neurology 94(15):e1592\u2013e1604. https:\/\/doi.org\/10.1212\/WNL.0000000000009249","journal-title":"Neurology"},{"issue":"9","key":"5602_CR70","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell H (2020) Glucose transporters in brain in health and disease. Pflugers Arch 472(9):1299\u20131343. https:\/\/doi.org\/10.1007\/s00424-020-02441-x","journal-title":"Pflugers Arch"},{"key":"5602_CR71","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3389\/fgene.2020.01022","volume":"11","author":"M Panahi","year":"2020","unstructured":"Panahi M, Rodriguez PR, Fereshtehnejad SM, Arafa D, Bogdanovic N, Winblad B, Cedazo-Minguez A, Rinne J et al (2020) Insulin-independent and dependent glucose transporters in brain mural cells in CADASIL. Front Genet 11:1022. https:\/\/doi.org\/10.3389\/fgene.2020.01022","journal-title":"Front Genet"},{"key":"5602_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.626636","volume":"15","author":"N Kyrtata","year":"2021","unstructured":"Kyrtata N, Emsley HCA, Sparasci O, Parkes LM, Dickie BR (2021) A systematic review of glucose transport alterations in Alzheimer\u2019s disease. Front Neurosci 15:626636. https:\/\/doi.org\/10.3389\/fnins.2021.626636","journal-title":"Front Neurosci"},{"issue":"1","key":"5602_CR73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm TV, Meier DT, Olefsky JM, Donath MY (2022) Inflammation in obesity, diabetes, and related disorders. Immunity 55(1):31\u201355. https:\/\/doi.org\/10.1016\/j.immuni.2021.12.013","journal-title":"Immunity"},{"issue":"6","key":"5602_CR74","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1021\/pr300021e","volume":"11","author":"D Hartl","year":"2012","unstructured":"Hartl D, Schuldt V, Forler S, Zabel C, Klose J, Rohe M (2012) Presymptomatic alterations in energy metabolism and oxidative stress in the APP23 mouse model of Alzheimer disease. J Proteome Res 11(6):3295\u20133304. https:\/\/doi.org\/10.1021\/pr300021e","journal-title":"J Proteome Res"},{"key":"5602_CR75","doi-asserted-by":"publisher","first-page":"101503","DOI":"10.1016\/j.arr.2021.101503","volume":"72","author":"T Song","year":"2021","unstructured":"Song T, Song X, Zhu C, Patrick R, Skurla M, Santangelo I, Green M, Harper D et al (2021) Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer\u2019s disease: a meta-analysis of in vivo magnetic resonance spectroscopy studies. Ageing Res Rev 72:101503. https:\/\/doi.org\/10.1016\/j.arr.2021.101503","journal-title":"Ageing Res Rev"},{"issue":"Pt B","key":"5602_CR76","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.neuropharm.2017.09.016","volume":"136","author":"GS Bloom","year":"2018","unstructured":"Bloom GS, Lazo JS, Norambuena A (2018) Reduced brain insulin signaling: a seminal process in Alzheimer\u2019s disease pathogenesis. Neuropharmacology 136(Pt B):192\u2013195. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.09.016","journal-title":"Neuropharmacology"},{"issue":"6","key":"5602_CR77","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.neuint.2011.08.002","volume":"59","author":"T Nemoto","year":"2011","unstructured":"Nemoto T, Yanagita T, Satoh S, Maruta T, Kanai T, Murakami M, Wada A (2011) Insulin-induced neurite-like process outgrowth: acceleration of tau protein synthesis via a phosphoinositide 3-kinase~mammalian target of rapamycin pathway. Neurochem Int 59(6):880\u2013888. https:\/\/doi.org\/10.1016\/j.neuint.2011.08.002","journal-title":"Neurochem Int"},{"issue":"9","key":"5602_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094209","volume":"26","author":"T Ponce-Lopez","year":"2025","unstructured":"Ponce-Lopez T (2025) Peripheral inflammation and insulin resistance: their impact on blood-brain barrier integrity and glia activation in Alzheimer\u2019s disease. Int J Mol Sci 26(9):4209. https:\/\/doi.org\/10.3390\/ijms26094209","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5602_CR79","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/1673-5374.286950","volume":"16","author":"NA Santos","year":"2021","unstructured":"Santos NA, Kihara AH, Cardoso AC et al (2021) Mechanisms of neuroplasticity and brain degeneration: strategies for protection during the aging process. Neural Regen Res 16(1):58\u201367. https:\/\/doi.org\/10.4103\/1673-5374.286950","journal-title":"Neural Regen Res"},{"issue":"1","key":"5602_CR80","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/1673-5374.286952","volume":"16","author":"M Toricelli","year":"2021","unstructured":"Toricelli M, Pereira AAR, Souza Abrao G, Malerba HN, Maia J, Buck HS, Viel TA (2021) Mechanisms of neuroplasticity and brain degeneration: strategies for protection during the aging process. Neural Regen Res 16(1):58\u201367. https:\/\/doi.org\/10.4103\/1673-5374.286952","journal-title":"Neural Regen Res"},{"key":"5602_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.913693","volume":"14","author":"S Kawabata","year":"2022","unstructured":"Kawabata S (2022) Excessive\/aberrant and maladaptive synaptic plasticity: a hypothesis for the pathogenesis of Alzheimer\u2019s disease. Front Aging Neurosci 14:913693. https:\/\/doi.org\/10.3389\/fnagi.2022.913693","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"5602_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12292","volume":"8","author":"M Nayak","year":"2022","unstructured":"Nayak M, Das D, Pradhan J, Ahmed RG, Laureano-Melo R, Dandapat J (2022) Epigenetic signature in neural plasticity: the journey so far and journey ahead. Heliyon 8(12):e12292. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12292","journal-title":"Heliyon"},{"key":"5602_CR83","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41386-022-01370-w","volume":"48","author":"LG Appelbaum","year":"2023","unstructured":"Appelbaum LG, Shenasa MA, Stolz L et al (2023) Synaptic plasticity and mental health: methods, challenges and opportunities. Neuropsychopharmacology 48:113\u2013120. https:\/\/doi.org\/10.1038\/s41386-022-01370-w","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"5602_CR84","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.3390\/brainsci13121610","volume":"13","author":"P Marzola","year":"2023","unstructured":"Marzola P, Melzer T, Pavesi E, Gil-Mohapel J, Brocardo PS (2023) Exploring the role of neuroplasticity in development, aging, and neurodegeneration. Brain Sci 13(12):1610. https:\/\/doi.org\/10.3390\/brainsci13121610","journal-title":"Brain Sci"},{"key":"5602_CR85","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-neuro-090919-022842","volume":"43","author":"JC Magee","year":"2020","unstructured":"Magee JC, Grienberger C (2020) Synaptic plasticity forms and functions. Annu Rev Neurosci 43:95\u2013117. https:\/\/doi.org\/10.1146\/annurev-neuro-090919-022842","journal-title":"Annu Rev Neurosci"},{"issue":"3","key":"5602_CR86","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/jnr.10441","volume":"70","author":"B Teter","year":"2002","unstructured":"Teter B, Ashford JW (2002) Neuroplasticity in Alzheimer\u2019s disease. J Neurosci Res 70(3):402\u2013437. https:\/\/doi.org\/10.1002\/jnr.10441","journal-title":"J Neurosci Res"},{"key":"5602_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.696476","volume":"14","author":"Y Andrade-Talavera","year":"2021","unstructured":"Andrade-Talavera Y, Rodr\u00edguez-Moreno A (2021) Synaptic plasticity and oscillations in Alzheimer\u2019s disease: a complex picture of a multifaceted disease. Front Mol Neurosci 14:696476. https:\/\/doi.org\/10.3389\/fnmol.2021.696476","journal-title":"Front Mol Neurosci"},{"key":"5602_CR88","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F, Xue G (2024) The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci 16:1347987. https:\/\/doi.org\/10.3389\/fnagi.2024.1347987","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"5602_CR89","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/biom14070833","volume":"14","author":"Z Sun","year":"2024","unstructured":"Sun Z, Zhang X, So K-F, Jiang W, Chiu K (2024) Targeting microglia in Alzheimer\u2019s disease: pathogenesis and potential therapeutic strategies. Biomolecules 14(7):833. https:\/\/doi.org\/10.3390\/biom14070833","journal-title":"Biomolecules"},{"key":"5602_CR90","doi-asserted-by":"publisher","first-page":"9999146","DOI":"10.1155\/2021\/9999146","volume":"2021","author":"R K\u00f6lliker-Frers","year":"2021","unstructured":"K\u00f6lliker-Frers R, Udovin L, Otero-Losada M, Kobiec T, Herrera MI, Palacios J, Razzitte G, Capani F (2021) Neuroinflammation: an integrating overview of reactive-neuroimmune cell interactions in health and disease. Mediators Inflamm 2021:9999146. https:\/\/doi.org\/10.1155\/2021\/9999146","journal-title":"Mediators Inflamm"},{"issue":"10","key":"5602_CR91","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.tins.2023.07.009","volume":"46","author":"J Singh","year":"2023","unstructured":"Singh J, Habean ML, Panicker N (2023) Inflammasome assembly in neurodegenerative diseases. Trends Neurosci 46(10):814\u2013831. https:\/\/doi.org\/10.1016\/j.tins.2023.07.009","journal-title":"Trends Neurosci"},{"key":"5602_CR92","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40659-022-00404-3","volume":"55","author":"C Novoa","year":"2022","unstructured":"Novoa C, Salazar P, Cisternas P et al (2022) Inflammation context in Alzheimer\u2019s disease, a relationship intricate to define. Biol Res 55:39. https:\/\/doi.org\/10.1186\/s40659-022-00404-3","journal-title":"Biol Res"},{"key":"5602_CR93","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neubiorev.2014.01.010","volume":"42","author":"M Papa","year":"2014","unstructured":"Papa M, De Luca C, Petta F, Alberghina L, Cirillo G (2014) Astrocyte-neuron interplay in maladaptive plasticity. Neurosci Biobehav Rev 42:35\u201354. https:\/\/doi.org\/10.1016\/j.neubiorev.2014.01.010","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"5602_CR94","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa109","volume":"2","author":"J Rivers-Auty","year":"2020","unstructured":"Rivers-Auty J, Mather AE, Peters R, Lawrence CB, Brough D (2020) Anti-inflammatories in Alzheimer\u2019s disease-potential therapy or spurious correlate? Brain Commun 2(2):fcaa109. https:\/\/doi.org\/10.1093\/braincomms\/fcaa109","journal-title":"Brain Commun"},{"key":"5602_CR95","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbi.2022.07.164","volume":"106","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wernersbach I, Strehle J, Li S, Appel D, Klein M, Ritter K, Hummel R et al (2022) Early posttraumatic CSF1R inhibition via PLX3397 leads to time- and sex-dependent effects on inflammation and neuronal maintenance after traumatic brain injury in mice. Brain Behav Immun 106:49\u201366. https:\/\/doi.org\/10.1016\/j.bbi.2022.07.164","journal-title":"Brain Behav Immun"},{"issue":"6","key":"5602_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27061816","volume":"27","author":"ZR Chen","year":"2022","unstructured":"Chen ZR, Huang JB, Yang SL, Hong FF (2022) Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules 27(6):1816. https:\/\/doi.org\/10.3390\/molecules27061816","journal-title":"Molecules"},{"issue":"6","key":"5602_CR97","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1111\/jnc.15471","volume":"158","author":"C Geula","year":"2021","unstructured":"Geula C, Dunlop SR, Ayala I, Kawles AS, Flanagan ME, Gefen T, Mesulam MM (2021) Basal forebrain cholinergic system in the dementias: vulnerability, resilience, and resistance. J Neurochem 158(6):1394\u20131411. https:\/\/doi.org\/10.1111\/jnc.15471","journal-title":"J Neurochem"},{"key":"5602_CR98","unstructured":"Sam C, Bordoni B. Physiology, Acetylcholine. [Updated 2023 Apr 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557825\/"},{"key":"5602_CR99","doi-asserted-by":"publisher","first-page":"105473","DOI":"10.1016\/j.nbd.2021.105473","volume":"158","author":"JR Crittenden","year":"2021","unstructured":"Crittenden JR, Zhai S, Sauvage M, Kitsukawa T, Burgui\u00e8re E, Thomsen M, Zhang H, Costa C et al (2021) Caldag-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors. Neurobiol Dis 158:105473. https:\/\/doi.org\/10.1016\/j.nbd.2021.105473","journal-title":"Neurobiol Dis"},{"key":"5602_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.998224","volume":"16","author":"FE Pozzi","year":"2022","unstructured":"Pozzi FE, Conti E, Appollonio I, Ferrarese C, Tremolizzo L (2022) Predictors of response to acetylcholinesterase inhibitors in dementia: a systematic review. Front Neurosci 16:998224. https:\/\/doi.org\/10.3389\/fnins.2022.998224","journal-title":"Front Neurosci"},{"issue":"9","key":"5602_CR101","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.3390\/ijms22094642","volume":"22","author":"CA Juan","year":"2021","unstructured":"Juan CA, P\u00e9rez de la Lastra JM, Plou FJ, P\u00e9rez-Lebe\u00f1a E (2021) The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies. Int J Mol Sci 22(9):4642. https:\/\/doi.org\/10.3390\/ijms22094642","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5602_CR102","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/jdad2020017","volume":"2","author":"AE Alkhalifa","year":"2025","unstructured":"Alkhalifa AE, Alkhalifa O, Durdanovic I, Ibrahim DR, Maragkou S (2025) Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease: insights into pathophysiology and treatment. J Dement Alzheimer\u2019s Dis 2(2):17. https:\/\/doi.org\/10.3390\/jdad2020017","journal-title":"J Dement Alzheimer's Dis"},{"issue":"17","key":"5602_CR103","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1021\/acschemneuro.3c00486","volume":"14","author":"RG Roy","year":"2023","unstructured":"Roy RG, Mandal PK, Maroon JC (2023) Oxidative stress occurs prior to amyloid A\u03b2 plaque formation and tau phosphorylation in Alzheimer\u2019s disease: role of glutathione and metal ions. ACS Chem Neurosci 14(17):2944\u20132954. https:\/\/doi.org\/10.1021\/acschemneuro.3c00486","journal-title":"ACS Chem Neurosci"},{"key":"5602_CR104","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.arr.2014.06.002","volume":"16","author":"A Rijpma","year":"2014","unstructured":"Rijpma A, Meulenbroek O, Olde Rikkert MG (2014) Cholinesterase inhibitors and add-on nutritional supplements in Alzheimer\u2019s disease: a systematic review of randomized controlled trials. Ageing Res Rev 16:105\u2013112. https:\/\/doi.org\/10.1016\/j.arr.2014.06.002","journal-title":"Ageing Res Rev"},{"issue":"3","key":"5602_CR105","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3233\/JAD-180766","volume":"67","author":"JL Cummings","year":"2019","unstructured":"Cummings JL, Tong G, Ballard C (2019) Treatment combinations for Alzheimer\u2019s disease: current and future pharmacotherapy options. J Alzheimer\u2019s Dis: JAD 67(3):779\u2013794. https:\/\/doi.org\/10.3233\/JAD-180766","journal-title":"J Alzheimer's Dis: JAD"},{"key":"5602_CR106","doi-asserted-by":"publisher","first-page":"9812178","DOI":"10.1155\/2016\/9812178","volume":"2016","author":"JS Crist\u00f3v\u00e3o","year":"2016","unstructured":"Crist\u00f3v\u00e3o JS, Santos R, Gomes CM (2016) Metals and neuronal metal binding proteins implicated in Alzheimer\u2019s disease. Oxid Med Cell Longev 2016:9812178. https:\/\/doi.org\/10.1155\/2016\/9812178","journal-title":"Oxid Med Cell Longev"},{"key":"5602_CR107","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-020-00189-z","volume":"9","author":"L Wang","year":"2020","unstructured":"Wang L, Yin YL, Liu XZ, Shen P, Zheng YG, Lan XR, Lu CB, Wang JZ (2020) Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease. Transl Neurodegener 9:10. https:\/\/doi.org\/10.1186\/s40035-020-00189-z","journal-title":"Transl Neurodegener"},{"issue":"5","key":"5602_CR108","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1021\/acsomega.2c06939","volume":"8","author":"N Puentes-D\u00edaz","year":"2023","unstructured":"Puentes-D\u00edaz N, Chaparro D, Morales-Morales D, Flores-Gaspar A, Al\u00ed-Torres J (2023) Role of metal cations of copper, iron, and aluminum and multifunctional ligands in Alzheimer\u2019s disease: experimental and computational insights. ACS Omega 8(5):4508\u20134526. https:\/\/doi.org\/10.1021\/acsomega.2c06939","journal-title":"ACS Omega"},{"issue":"1","key":"5602_CR109","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/JAD-130209","volume":"37","author":"EP Raven","year":"2013","unstructured":"Raven EP, Lu PH, Tishler TA, Heydari P, Bartzokis G (2013) Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer\u2019s disease detected in vivo with magnetic resonance imaging. J Alzheimer\u2019s Dis: JAD 37(1):127\u2013136. https:\/\/doi.org\/10.3233\/JAD-130209","journal-title":"J Alzheimer's Dis: JAD"},{"issue":"11","key":"5602_CR110","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1021\/jacsau.2c00438","volume":"2","author":"A Abelein","year":"2022","unstructured":"Abelein A, Ciofi-Baffoni S, M\u00f6rman C, Kumar R, Giachetti A, Piccioli M, Biverst\u00e5l H (2022) Molecular structure of Cu(II)-bound amyloid-\u03b2 monomer implicated in inhibition of peptide self-assembly in Alzheimer\u2019s disease. JACS Au 2(11):2571\u20132584. https:\/\/doi.org\/10.1021\/jacsau.2c00438","journal-title":"JACS Au"},{"issue":"48","key":"5602_CR111","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036375","volume":"102","author":"D Feng","year":"2023","unstructured":"Feng D, Zhao Y, Li W, Li X, Wan J, Wang F (2023) Copper neurotoxicity: induction of cognitive dysfunction: A review. Medicine (Baltimore) 102(48):e36375. https:\/\/doi.org\/10.1097\/MD.0000000000036375","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"5602_CR112","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.3390\/nu15092140","volume":"15","author":"B Wang","year":"2023","unstructured":"Wang B, Fang T, Chen H (2023) Zinc and central nervous system disorders. Nutrients 15(9):2140. https:\/\/doi.org\/10.3390\/nu15092140","journal-title":"Nutrients"},{"key":"5602_CR113","doi-asserted-by":"publisher","unstructured":"Vilella A, Daini E, De Benedictis CA, Grabrucker AM (2020) Targeting metal homeostasis as a therapeutic strategy for Alzheimer\u2019s disease. In X. Huang (Ed.), Alzheimer\u2019s Disease: Drug Discovery. Exon Publications. https:\/\/doi.org\/10.36255\/exonpublications.alzheimersdisease.2020.ch5","DOI":"10.36255\/exonpublications.alzheimersdisease.2020.ch5"},{"issue":"2","key":"5602_CR114","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/nu10020147","volume":"10","author":"M Kawahara","year":"2018","unstructured":"Kawahara M, Tanaka KI, Kato-Negishi M (2018) Zinc, carnosine, and neurodegenerative diseases. Nutrients 10(2):147. https:\/\/doi.org\/10.3390\/nu10020147","journal-title":"Nutrients"},{"issue":"12","key":"5602_CR115","doi-asserted-by":"publisher","first-page":"6521","DOI":"10.3390\/ijms25126521","volume":"25","author":"N Nicosia","year":"2024","unstructured":"Nicosia N, Giovenzana M, Misztak P, Mingardi J, Musazzi L (2024) Glutamate-mediated excitotoxicity in the pathogenesis and treatment of neurodevelopmental and adult mental disorders. Int J Mol Sci 25(12):6521. https:\/\/doi.org\/10.3390\/ijms25126521","journal-title":"Int J Mol Sci"},{"key":"5602_CR116","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3389\/fnins.2020.00861","volume":"4","author":"J Wang","year":"2020","unstructured":"Wang J, Swanson RA (2020) Superoxide and non-ionotropic signaling in neuronal excitotoxicity. Front Neurosci 4:861. https:\/\/doi.org\/10.3389\/fnins.2020.00861","journal-title":"Front Neurosci"},{"issue":"6","key":"5602_CR117","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1007\/s12035-020-01871-z","volume":"57","author":"H Hou","year":"2020","unstructured":"Hou H, Wang L, Fu T, Papasergi M, Yule DI, Xia H (2020) Magnesium acts as a second messenger in the regulation of NMDA receptor-mediated CREB signaling in neurons. Mol Neurobiol 57(6):2539\u20132550. https:\/\/doi.org\/10.1007\/s12035-020-01871-z","journal-title":"Mol Neurobiol"},{"issue":"4","key":"5602_CR118","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s13311-016-0477-8","volume":"13","author":"E Cekanaviciute","year":"2016","unstructured":"Cekanaviciute E, Buckwalter MS (2016) Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases. Neurotherapeutics 13(4):685\u2013701. https:\/\/doi.org\/10.1007\/s13311-016-0477-8","journal-title":"Neurotherapeutics"},{"issue":"4","key":"5602_CR119","doi-asserted-by":"publisher","first-page":"566","DOI":"10.25259\/JNRP_356_2023","volume":"14","author":"A Varadharajan","year":"2023","unstructured":"Varadharajan A, Davis AD, Ghosh A, Jagtap T, Xavier A, Menon AJ, Roy D, Gandhi S et al (2023) Guidelines for pharmacotherapy in Alzheimer\u2019s disease - a primer on FDA-approved drugs. J Neurosci Rural Pract 14(4):566\u2013573. https:\/\/doi.org\/10.25259\/JNRP_356_2023","journal-title":"J Neurosci Rural Pract"},{"key":"5602_CR120","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04333-y","author":"E Akyuz","year":"2024","unstructured":"Akyuz E, Arulsamy A, Aslan FS et al (2024) An expanded narrative review of neurotransmitters on Alzheimer\u2019s disease: the role of therapeutic interventions on neurotransmission. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04333-y","journal-title":"Mol Neurobiol"},{"issue":"12","key":"5602_CR121","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1038\/s41380-023-02140-w","volume":"28","author":"G Carello-Collar","year":"2023","unstructured":"Carello-Collar G, Bellaver B, Ferreira PCL, Ferrari-Souza JP, Ramos VG, Therriault J, Tissot C, Bastiani MA et al (2023) The GABAergic system in Alzheimer\u2019s disease: a systematic review with meta-analysis. Mol Psychiatry 28(12):5025\u20135036. https:\/\/doi.org\/10.1038\/s41380-023-02140-w","journal-title":"Mol Psychiatry"},{"key":"5602_CR122","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.bbi.2024.09.033","volume":"123","author":"S Malan-M\u00fcller","year":"2025","unstructured":"Malan-M\u00fcller S, Mart\u00edn-Hern\u00e1ndez D, Caso JR, Matthijnssens J, Rodr\u00edguez-Urrutia A, Lowry CA, Leza JC (2025) Metagenomic symphony of the intestinal ecosystem: how the composition affects the mind. Brain Behav Immun 123:510\u2013523. https:\/\/doi.org\/10.1016\/j.bbi.2024.09.033","journal-title":"Brain Behav Immun"},{"issue":"2","key":"5602_CR123","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3390\/nu13020690","volume":"13","author":"U Shabbir","year":"2021","unstructured":"Shabbir U, Arshad MS, Sameen A, Oh DH (2021) Crosstalk between gut and brain in Alzheimer\u2019s disease: the role of gut microbiota modulation strategies. Nutrients 13(2):690. https:\/\/doi.org\/10.3390\/nu13020690","journal-title":"Nutrients"},{"issue":"1","key":"5602_CR124","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13195-023-01218-5","volume":"15","author":"M Marizzoni","year":"2023","unstructured":"Marizzoni M, Mirabelli P, Mombelli E, Coppola L, Festari C, Lopizzo N, Luongo D, Mazzelli M et al (2023) A peripheral signature of Alzheimer\u2019s disease featuring microbiota-gut-brain axis markers. Alzheimers Res Ther 15(1):101. https:\/\/doi.org\/10.1186\/s13195-023-01218-5","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"5602_CR125","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","volume":"19","author":"F Di Vincenzo","year":"2024","unstructured":"Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F (2024) Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med 19(2):275\u2013293. https:\/\/doi.org\/10.1007\/s11739-023-03374-w","journal-title":"Intern Emerg Med"},{"issue":"4","key":"5602_CR126","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","volume":"78","author":"A Ciesielska","year":"2021","unstructured":"Ciesielska A, Matyjek M, Kwiatkowska K (2021) TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci: CMLS 78(4):1233\u20131261. https:\/\/doi.org\/10.1007\/s00018-020-03656-y","journal-title":"Cell Mol Life Sci: CMLS"},{"issue":"17","key":"5602_CR127","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111515","volume":"42","author":"J Xie","year":"2023","unstructured":"Xie J, Bruggeman A, De Nolf C, Vandendriessche C, Van Imschoot G, Van Wonterghem E, Vereecke L, Vandenbroucke RE (2023) Gut microbiota regulates blood-cerebrospinal fluid barrier function and A\u03b2 pathology. EMBO J 42(17):e111515. https:\/\/doi.org\/10.15252\/embj.2022111515","journal-title":"EMBO J"},{"issue":"1","key":"5602_CR128","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13195-018-0451-2","volume":"10","author":"NM Vogt","year":"2018","unstructured":"Vogt NM, Romano KA, Darst BF, Engelman CD, Johnson SC, Carlsson CM, Asthana S, Blennow K et al (2018) The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer\u2019s disease. Alzheimers Res Ther 10(1):124. https:\/\/doi.org\/10.1186\/s13195-018-0451-2","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"5602_CR129","doi-asserted-by":"publisher","first-page":"e70601","DOI":"10.1096\/fj.202403117RR","volume":"39","author":"F Eid","year":"2025","unstructured":"Eid F, Boushehri M, Boucher C, Rajkanth N, Sa AF, Alhoutan T, Vavetsi K, Dibart S et al (2025) Chronic lipopolysaccharide exposure causes AD-like pathology in male mice with intact blood-brain barrier. FASEB J 39(9):e70601. https:\/\/doi.org\/10.1096\/fj.202403117RR","journal-title":"FASEB J"},{"key":"5602_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118627","volume":"264","author":"P Kesika","year":"2021","unstructured":"Kesika P, Suganthy N, Sivamaruthi BS, Chaiyasut C (2021) Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer\u2019s disease. Life Sci 264:118627. https:\/\/doi.org\/10.1016\/j.lfs.2020.118627","journal-title":"Life Sci"},{"key":"5602_CR131","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s12276-023-01146-2","volume":"56","author":"Do Seo","year":"2024","unstructured":"Seo Do, Holtzman DM (2024) Current understanding of the Alzheimer\u2019s disease-associated microbiome and therapeutic strategies. Exp Mol Med 56:86\u201394. https:\/\/doi.org\/10.1038\/s12276-023-01146-2","journal-title":"Exp Mol Med"},{"issue":"1","key":"5602_CR132","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.1038\/s41467-023-41283-w","volume":"14","author":"Y Xia","year":"2023","unstructured":"Xia Y, Xiao Y, Wang ZH, Liu X, Alam AM, Haran JP, McCormick BA, Shu X et al (2023) Bacteroides fragilis in the gut microbiomes of Alzheimer\u2019s disease activates microglia and triggers pathogenesis in neuronal C\/EBP\u03b2 transgenic mice. Nat Commun 14(1):5471. https:\/\/doi.org\/10.1038\/s41467-023-41283-w","journal-title":"Nat Commun"},{"issue":"15","key":"5602_CR133","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.3390\/cells11152262","volume":"11","author":"L G\u00f3mez-Virgilio","year":"2022","unstructured":"G\u00f3mez-Virgilio L, Silva-Lucero MD, Flores-Morelos DS, Gallardo-Nieto J, Lopez-Toledo G, Abarca-Fernandez AM, Zacapala-G\u00f3mez AE, Luna-Mu\u00f1oz J et al (2022) Autophagy: a key regulator of homeostasis and disease: an overview of molecular mechanisms and modulators. Cells 11(15):2262. https:\/\/doi.org\/10.3390\/cells11152262","journal-title":"Cells"},{"issue":"5","key":"5602_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.347","volume":"4","author":"R Yao","year":"2023","unstructured":"Yao R, Shen J (2023) Chaperone-mediated autophagy: Molecular mechanisms, biological functions, and diseases. MedComm 4(5):e347. https:\/\/doi.org\/10.1002\/mco2.347","journal-title":"MedComm"},{"key":"5602_CR135","doi-asserted-by":"publisher","unstructured":"Morishita H, Mizushima N (2019) A comprehensive review of autophagy and its various roles in infectious, non-Infectious, and lifestyle diseases: current knowledge and prospects for disease prevention, novel drug design, and therapy. Cells, 8(4), 410. Knockdown of Amyloid Precursor Protein: Biological Consequences and Clinical Opportunities - PubMed https:\/\/doi.org\/10.3390\/cells8040410","DOI":"10.3390\/cells8040410"},{"issue":"1","key":"5602_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/cells13010103","volume":"13","author":"C Li\u00e9nard","year":"2024","unstructured":"Li\u00e9nard C, Pintart A, Bomont P (2024) Neuronal autophagy: regulations and implications in health and disease. Cells 13(1):103. https:\/\/doi.org\/10.3390\/cells13010103","journal-title":"Cells"},{"issue":"1","key":"5602_CR137","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","volume":"141","author":"L Vaillant-Beuchot","year":"2021","unstructured":"Vaillant-Beuchot L, Mary A, Pardossi-Piquard R, Bourgeois A, Lauritzen I, Eysert F, Kinoshita PF, Cazareth J et al (2021) Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer\u2019s disease models and human brains. Acta Neuropathol 141(1):39\u201365. https:\/\/doi.org\/10.1007\/s00401-020-02234-7","journal-title":"Acta Neuropathol"},{"key":"5602_CR138","doi-asserted-by":"publisher","first-page":"1394932","DOI":"10.3389\/fnmol.2024.1394932","volume":"17","author":"Y Lyu","year":"2024","unstructured":"Lyu Y, Meng Z, Hu Y, Jiang B, Yang J, Chen Y, Zhou J, Li M et al (2024) Mechanisms of mitophagy and oxidative stress in cerebral ischemia-reperfusion, vascular dementia, and Alzheimer\u2019s disease. Front Mol Neurosci 17:1394932. https:\/\/doi.org\/10.3389\/fnmol.2024.1394932","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"5602_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02866-y","volume":"20","author":"JD Quick","year":"2023","unstructured":"Quick JD, Silva C, Wong JH, Lim KL, Reynolds R, Barron AM, Zeng J, Lo CH (2023) Lysosomal acidification dysfunction in microglia: an emerging pathogenic mechanism of neuroinflammation and neurodegeneration. J Neuroinflammation 20(1):185. https:\/\/doi.org\/10.1186\/s12974-023-02866-y","journal-title":"J Neuroinflammation"},{"issue":"11","key":"5602_CR140","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1080\/15548627.2023.2235196","volume":"19","author":"L Qiao","year":"2023","unstructured":"Qiao L, Hu J, Qiu X, Wang C, Peng J, Zhang C, Zhang M, Lu H et al (2023) LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles. Autophagy 19(11):2837\u20132852. https:\/\/doi.org\/10.1080\/15548627.2023.2235196","journal-title":"Autophagy"},{"issue":"10","key":"5602_CR141","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s13238-021-00858-3","volume":"12","author":"X Xu","year":"2021","unstructured":"Xu X, Sun Y, Cen X, Shan B, Zhao Q, Xie T, Wang Z, Hou T et al (2021) Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model. Protein Cell 12(10):769\u2013787. https:\/\/doi.org\/10.1007\/s13238-021-00858-3","journal-title":"Protein Cell"},{"key":"5602_CR142","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nbd.2018.04.017","volume":"122","author":"OJ Lieberman","year":"2019","unstructured":"Lieberman OJ, McGuirt AF, Tang G, Sulzer D (2019) Roles for neuronal and glial autophagy in synaptic pruning during development. Neurobiol Dis 122:49\u201363. https:\/\/doi.org\/10.1016\/j.nbd.2018.04.017","journal-title":"Neurobiol Dis"},{"issue":"4","key":"5602_CR143","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3233\/JAD-210095","volume":"81","author":"F Du","year":"2021","unstructured":"Du F, Yu Q, Yan SS (2021) PINK1 activation attenuates impaired neuronal-like differentiation and synaptogenesis and mitochondrial dysfunction in Alzheimer\u2019s disease trans-mitochondrial cybrid cells. J Alzheimer\u2019s Dis: JAD 81(4):1749\u20131761. https:\/\/doi.org\/10.3233\/JAD-210095","journal-title":"J Alzheimer's Dis: JAD"},{"key":"5602_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114436","volume":"366","author":"Y Tang","year":"2023","unstructured":"Tang Y, Liu Y, Zhou H, Lu H, Zhang Y, Hua J, Liao X (2023) Esketamine is neuroprotective against traumatic brain injury through its modulation of autophagy and oxidative stress via AMPK\/mTOR-dependent TFEB nuclear translocation. Exp Neurol 366:114436. https:\/\/doi.org\/10.1016\/j.expneurol.2023.114436","journal-title":"Exp Neurol"},{"issue":"10","key":"5602_CR145","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.3390\/cells10102557","volume":"10","author":"TA Korolenko","year":"2021","unstructured":"Korolenko TA, Dubrovina NI, Ovsyukova MV, Bgatova NP, Tenditnik MV, Pupyshev AB, Akopyan AA, Goncharova NV et al (2021) Treatment with autophagy inducer trehalose alleviates memory and behavioral impairments and neuroinflammatory brain processes in db\/db mice. Cells 10(10):2557. https:\/\/doi.org\/10.3390\/cells10102557","journal-title":"Cells"},{"key":"5602_CR146","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fcell.2019.00038","volume":"7","author":"PK Panda","year":"2019","unstructured":"Panda PK, Fahrner A, Vats S, Seranova E, Sharma V, Chipara M, Desai P, Torresi J et al (2019) Chemical screening approaches enabling drug discovery of autophagy modulators for biomedical applications in human diseases. Front Cell Dev Biol 7:38. https:\/\/doi.org\/10.3389\/fcell.2019.00038","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"5602_CR147","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.3390\/ijms22073330","volume":"22","author":"M Eshraghi","year":"2021","unstructured":"Eshraghi M, Adlimoghaddam A, Mahmoodzadeh A, Sharifzad F, Yasavoli-Sharahi H, Lorzadeh S, Albensi BC, Ghavami S (2021) Alzheimer\u2019s disease pathogenesis: role of autophagy and mitophagy focusing in microglia. Int J Mol Sci 22(7):3330. https:\/\/doi.org\/10.3390\/ijms22073330","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5602_CR148","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/ijms24043754","volume":"24","author":"J Andrade-Guerrero","year":"2023","unstructured":"Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodr\u00edguez I, Cadena-Su\u00e1rez AR, S\u00e1nchez-Garibay C, Pozo-Molina G, M\u00e9ndez-Catal\u00e1 CF et al (2023) Alzheimer\u2019s disease: an updated overview of its genetics. Int J Mol Sci 24(4):3754. https:\/\/doi.org\/10.3390\/ijms24043754","journal-title":"Int J Mol Sci"},{"key":"5602_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.695808","volume":"13","author":"X Xiao","year":"2021","unstructured":"Xiao X, Liu H, Liu X, Zhang W, Zhang S, Jiao B (2021) APP, PSEN1, and PSEN2 variants in Alzheimer\u2019s disease: systematic re-evaluation according to ACMG guidelines. Front Aging Neurosci 13:695808. https:\/\/doi.org\/10.3389\/fnagi.2021.695808","journal-title":"Front Aging Neurosci"},{"key":"5602_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.835645","volume":"16","author":"RMC Gabriele","year":"2022","unstructured":"Gabriele RMC, Abel E, Fox NC, Wray S, Arber C (2022) Knockdown of amyloid precursor protein: biological consequences and clinical opportunities. Front Neurosci 16:835645. https:\/\/doi.org\/10.3389\/fnins.2022.835645","journal-title":"Front Neurosci"},{"issue":"6","key":"5602_CR151","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/alz.12463","volume":"18","author":"M Sawa","year":"2022","unstructured":"Sawa M, Overk C, Becker A, Derse D, Albay R, Weldy K, Salehi A, Beach TG et al (2022) Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model. Alzheimers Dement 18(6):1203\u20131234. https:\/\/doi.org\/10.1002\/alz.12463","journal-title":"Alzheimers Dement"},{"issue":"2","key":"5602_CR152","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-160836","volume":"56","author":"E Doran","year":"2017","unstructured":"Doran E, Keator D, Head E, Phelan MJ, Kim R, Totoiu M, Barrio JR, Small GW et al (2017) Down syndrome, partial trisomy 21, and absence of Alzheimer\u2019s disease: the role of APP. J Alzheimers Dis 56(2):459\u2013470. https:\/\/doi.org\/10.3233\/JAD-160836","journal-title":"J Alzheimers Dis"},{"key":"5602_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.909669","volume":"16","author":"C Farrell","year":"2022","unstructured":"Farrell C, Mumford P, Wiseman FK (2022) Rodent modeling of Alzheimer\u2019s disease in Down syndrome: in vivo and ex vivo approaches. Front Neurosci 16:909669. https:\/\/doi.org\/10.3389\/fnins.2022.909669","journal-title":"Front Neurosci"},{"issue":"1","key":"5602_CR154","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC (2022) ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener 17(1):72. https:\/\/doi.org\/10.1186\/s13024-022-00574-4","journal-title":"Mol Neurodegener"},{"issue":"3","key":"5602_CR155","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00401-022-02467-8","volume":"144","author":"D Sepulveda-Falla","year":"2022","unstructured":"Sepulveda-Falla D, Sanchez JS, Almeida MC, Boassa D, Acosta-Uribe J, Vila-Castelar C, Ramirez-Gomez L, Baena A et al (2022) Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer\u2019s dementia. Acta Neuropathol 144(3):589\u2013601. https:\/\/doi.org\/10.1007\/s00401-022-02467-8","journal-title":"Acta Neuropathol"},{"key":"5602_CR156","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-023-01127-y","volume":"13","author":"V Rudajev","year":"2023","unstructured":"Rudajev V, Novotny J (2023) Cholesterol-dependent amyloid \u03b2 production: space for multifarious interactions between amyloid precursor protein, secretases, and cholesterol. Cell Biosci 13:171. https:\/\/doi.org\/10.1186\/s13578-023-01127-y","journal-title":"Cell Biosci"},{"key":"5602_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104976","volume":"143","author":"SM Neuner","year":"2020","unstructured":"Neuner SM, Tcw J, Goate AM (2020) Genetic architecture of Alzheimer\u2019s disease. Neurobiol Dis 143:104976. https:\/\/doi.org\/10.1016\/j.nbd.2020.104976","journal-title":"Neurobiol Dis"},{"issue":"11","key":"5602_CR158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008596","volume":"16","author":"CE Seaks","year":"2020","unstructured":"Seaks CE, Wilcock DM (2020) Infectious hypothesis of Alzheimer disease. PLoS Pathog 16(11):e1008596. https:\/\/doi.org\/10.1371\/journal.ppat.1008596","journal-title":"PLoS Pathog"},{"key":"5602_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101723","volume":"81","author":"G Pasqualetti","year":"2022","unstructured":"Pasqualetti G, Thayanandan T, Edison P (2022) Influence of genetic and cardiometabolic risk factors in Alzheimer\u2019s disease. Ageing Res Rev 81:101723. https:\/\/doi.org\/10.1016\/j.arr.2022.101723","journal-title":"Ageing Res Rev"},{"issue":"12","key":"5602_CR160","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41588-022-01208-7","volume":"54","author":"H Holstege","year":"2022","unstructured":"Holstege H, Hulsman M, Charbonnier C, Grenier-Boley B, Quenez O, Grozeva D, van Rooij JGJ, Sims R et al (2022) Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer\u2019s disease. Nature genetics 54(12):1786\u20131794. https:\/\/doi.org\/10.1038\/s41588-022-01208-7","journal-title":"Nature genetics"},{"key":"5602_CR161","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9895121","volume":"2020","author":"BT Assefa","year":"2020","unstructured":"Assefa BT, Tafere GG, Wondafrash DZ, Gidey MT (2020) The bewildering effect of AMPK activators in Alzheimer\u2019s disease: review of the current evidence. BioMed Res Int 2020:9895121. https:\/\/doi.org\/10.1155\/2020\/9895121","journal-title":"BioMed Res Int"},{"issue":"3","key":"5602_CR162","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10030074","volume":"10","author":"SX Naughton","year":"2020","unstructured":"Naughton SX, Raval U, Pasinetti GM (2020) The viral hypothesis in Alzheimer\u2019s disease: novel insights and pathogen-based biomarkers. J Pers Med 10(3):74. https:\/\/doi.org\/10.3390\/jpm10030074","journal-title":"J Pers Med"},{"key":"5602_CR163","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13116","volume":"33","author":"OV Bocharova","year":"2022","unstructured":"Bocharova OV, Fisher A, Pandit NP, Molesworth K, Mychko O, Scott AJ, Makarava N, Ritzel R, et al. (2022) A\u03b2 plaques do not protect against HSV-1 infection in a mouse model of familial Alzheimer\u2019s disease, and HSV-1 does not induce A\u03b2 pathology in a model of late onset Alzheimer\u2019s disease. Brain Pathol 33:e13116. https:\/\/doi.org\/10.1111\/bpa.13116","journal-title":"Brain Pathol"},{"key":"5602_CR164","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40035-023-00369-7","volume":"12","author":"CSG Catumbela","year":"2023","unstructured":"Catumbela CSG, Giridharan VV, Barichello T et al (2023) Clinical evidence of human pathogens implicated in Alzheimer\u2019s disease pathology and the therapeutic efficacy of antimicrobials: an overview. Transl Neurodegener 12:37. https:\/\/doi.org\/10.1186\/s40035-023-00369-7","journal-title":"Transl Neurodegener"},{"issue":"1","key":"5602_CR165","doi-asserted-by":"publisher","first-page":"43","DOI":"10.14336\/AD.2023.0608","volume":"15","author":"M Nasb","year":"2024","unstructured":"Nasb M, Tao W, Chen N (2024) Alzheimer\u2019s disease puzzle: delving into pathogenesis hypotheses. Aging and disease 15(1):43\u201373. https:\/\/doi.org\/10.14336\/AD.2023.0608","journal-title":"Aging and disease"},{"issue":"4","key":"5602_CR166","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1007\/s13311-021-01112-8","volume":"18","author":"KL Tyler","year":"2021","unstructured":"Tyler KL (2021) The link between Alzheimer disease and herpes simplex virus infection: better late than never, or better never than late? Neurotherapeutics 18(4):2421\u20132424. https:\/\/doi.org\/10.1007\/s13311-021-01112-8","journal-title":"Neurotherapeutics"},{"issue":"7","key":"5602_CR167","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3390\/microorganisms8070972","volume":"8","author":"V Protto","year":"2020","unstructured":"Protto V, Tramutola A, Fabiani M, Marcocci ME, Napoletani G, Iavarone F, Vincenzoni F, Castagnola M et al (2020) Multiple herpes simplex virus-1 (HSV-1) reactivations induce protein oxidative damage in mouse brain: novel mechanisms for Alzheimer\u2019s disease progression. Microorganisms 8(7):972. https:\/\/doi.org\/10.3390\/microorganisms8070972","journal-title":"Microorganisms"},{"key":"5602_CR168","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-2627-5_1","volume":"1303","author":"JI Castrillo","year":"2016","unstructured":"Castrillo JI, Oliver SG (2016) Alzheimer\u2019s as a systems-level disease involving the interplay of multiple cellular networks. Methods Mol Biol (Clifton, N.J) 1303:3\u201348. https:\/\/doi.org\/10.1007\/978-1-4939-2627-5_1","journal-title":"Methods Mol Biol (Clifton, N.J)"},{"key":"5602_CR169","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.freeradbiomed.2023.08.028","volume":"208","author":"MI Holubiec","year":"2023","unstructured":"Holubiec MI, Alloatti M, Bianchelli J, Greloni F, Arnaiz C, Gonzalez Prinz M, Fernandez Bessone I, Pozo Devoto V, et al. (2023) Mitochondrial vulnerability to oxidation in human brain organoids modelling Alzheimer\u2019s disease. Free Radic Biol Med 208:394\u2013401. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.08.028","journal-title":"Free Radic Biol Med"},{"key":"5602_CR170","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.molimm.2018.09.010","volume":"103","author":"Q Liu","year":"2018","unstructured":"Liu Q, Zhang D, Hu D, Zhou X, Zhou Y (2018) The role of mitochondria in NLRP3 inflammasome activation. Mol Immunol 103:115\u2013124. https:\/\/doi.org\/10.1016\/j.molimm.2018.09.010","journal-title":"Mol Immunol"},{"issue":"3","key":"5602_CR171","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70306","volume":"31","author":"P Wei","year":"2025","unstructured":"Wei P, Lin K, Chen X, Fang C, Qiu L, Hu J, Chang J (2025) Sequential proteomic analysis reveals the key APOE4-induced pathological and molecular features at the presymptomatic stage in Alzheimer\u2019s disease mice. CNS Neurosci Ther 31(3):e70306. https:\/\/doi.org\/10.1111\/cns.70306","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"5602_CR172","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s11011-022-00914-9","volume":"37","author":"MS Tan","year":"2022","unstructured":"Tan MS, Liu Y, Hu H, Tan CC, Tan L (2022) Inhibition of caspase-1 ameliorates tauopathy and rescues cognitive impairment in SAMP8 mice. Metab Brain Dis 37(4):1197\u20131205. https:\/\/doi.org\/10.1007\/s11011-022-00914-9","journal-title":"Metab Brain Dis"},{"issue":"1","key":"5602_CR173","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0226-4","volume":"12","author":"F Llorens","year":"2017","unstructured":"Llorens F, Th\u00fcne K, Tahir W, Kanata E, Diaz-Lucena D, Xanthopoulos K, Kovatsi E, Pleschka C, et al. (2017) YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias. Mol Neurodegener 12(1):83. https:\/\/doi.org\/10.1186\/s13024-017-0226-4","journal-title":"Mol Neurodegener"},{"issue":"1","key":"5602_CR174","doi-asserted-by":"publisher","first-page":"e12001","DOI":"10.1002\/dad2.12001","volume":"12","author":"A Badhwar","year":"2020","unstructured":"Badhwar A, Haqqani AS (2020) Biomarker potential of brain-secreted extracellular vesicles in blood in Alzheimer\u2019s disease. Alzheimer\u2019s Dement (Amsterdam, Netherlands) 12(1):e12001. https:\/\/doi.org\/10.1002\/dad2.12001","journal-title":"Alzheimer's Dement (Amsterdam, Netherlands)"},{"issue":"4","key":"5602_CR175","doi-asserted-by":"publisher","first-page":"e3002607","DOI":"10.1371\/journal.pbio.3002607","volume":"22","author":"AM Eteleeb","year":"2024","unstructured":"Eteleeb AM, Novotny BC, Tarraga CS, Sohn C, Dhungel E, Brase L, Nallapu A, Buss J et al (2024) Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer\u2019s disease. PLoS Biol 22(4):e3002607. https:\/\/doi.org\/10.1371\/journal.pbio.3002607","journal-title":"PLoS Biol"},{"issue":"2","key":"5602_CR176","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3233\/JAD-210378","volume":"83","author":"ID Rasmussen","year":"2021","unstructured":"Rasmussen ID, Boayue NM, Mittner M, Bystad M, Gr\u00f8nli OK, Vangberg TR, Csifcs\u00e1k G, Aslaksen PM (2021) High-definition transcranial direct current stimulation improves delayed memory in Alzheimer\u2019s disease patients: a pilot study using computational modeling to optimize electrode position. J Alzheimer\u2019s Dis: JAD 83(2):753\u2013769. https:\/\/doi.org\/10.3233\/JAD-210378","journal-title":"J Alzheimer's Dis: JAD"},{"key":"5602_CR177","doi-asserted-by":"publisher","unstructured":"Geerts H, Hofmann-Apitius M, Anastasio TJ, Brain Health Modeling Initiative (2017) Knowledge-driven computational modeling in Alzheimer's disease research: Current state and future trends. Alzheimer's & dementia: the journal of the Alzheimer's Association, 13(11), 1292\u20131302. https:\/\/doi.org\/10.1016\/j.jalz.2017.08.011","DOI":"10.1016\/j.jalz.2017.08.011"},{"issue":"5","key":"5602_CR178","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.3390\/ijms22052761","volume":"22","author":"CH Chang","year":"2021","unstructured":"Chang CH, Lin CH, Lane HY (2021) Machine learning and novel biomarkers for the diagnosis of Alzheimer\u2019s disease. Int J Mol Sci 22(5):2761. https:\/\/doi.org\/10.3390\/ijms22052761","journal-title":"Int J Mol Sci"},{"key":"5602_CR179","doi-asserted-by":"publisher","first-page":"102846","DOI":"10.1016\/j.redox.2023.102846","volume":"66","author":"M Sangineto","year":"2023","unstructured":"Sangineto M, Ciarnelli M, Cassano T, Radesco A, Moola A, Bukke VN, Romano A, Villani R et al (2023) Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer\u2019s disease. Redox Biol 66:102846. https:\/\/doi.org\/10.1016\/j.redox.2023.102846","journal-title":"Redox Biol"},{"issue":"4","key":"5602_CR180","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/13543784.2020.1738383","volume":"29","author":"C H\u00f6lscher","year":"2020","unstructured":"H\u00f6lscher C (2020) Brain insulin resistance: role in neurodegenerative disease and potential for targeting. Expert Opin Investig Drugs 29(4):333\u2013348. https:\/\/doi.org\/10.1080\/13543784.2020.1738383","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"5602_CR181","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tem.2021.01.006","volume":"32","author":"M Falabella","year":"2021","unstructured":"Falabella M, Vernon HJ, Hanna MG, Claypool SM, Pitceathly RDS (2021) Cardiolipin, mitochondria, and neurological disease. Trends Endocrinol Metab 32(4):224\u2013237. https:\/\/doi.org\/10.1016\/j.tem.2021.01.006","journal-title":"Trends Endocrinol Metab"},{"issue":"15","key":"5602_CR182","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.3390\/nu15153454","volume":"15","author":"I Grabska-Koby\u0142ecka","year":"2023","unstructured":"Grabska-Koby\u0142ecka I, Szpakowski P, Kr\u00f3l A, Ksi\u0105\u017cek-Winiarek D, Koby\u0142ecki A, G\u0142\u0105bi\u0144ski A, Nowak D (2023) Polyphenols and their impact on the prevention of neurodegenerative diseases and development. Nutrients 15(15):3454. https:\/\/doi.org\/10.3390\/nu15153454","journal-title":"Nutrients"},{"issue":"2","key":"5602_CR183","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1142\/S0192415X23500179","volume":"51","author":"T Pairojana","year":"2023","unstructured":"Pairojana T, Phasuk S, Tantisira MH, Liang KC, Roytrakul S, Pakaprot N, Chompoopong S, Nudmamud-Thanoi S, et al. (2023) Standardized extract of Centella asiatica prevents fear memory deficit in 3xTg-AD mice. Am J Chin Med 51(2):329\u2013353. https:\/\/doi.org\/10.1142\/S0192415X23500179","journal-title":"Am J Chin Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05602-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05602-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05602-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T06:04:39Z","timestamp":1765433079000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05602-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":183,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5602"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05602-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"282"}}